FDA Announces New Recommendations for Acceptable Limits of Nitrosamine in Drugs
The FDA has released new guidance on acceptable intake limits for certain nitrosamines and how drug manufacturers should test for them.
The FDA has released new guidance on acceptable intake limits for certain nitrosamines and how drug manufacturers should test for them.
Merck indicates it will remove nitrosamine contaminants from Januvia and Janumet by the end of 2023.
The FDA has been caught off-guard by the number of drugs being recalled for nitrosamine contamination and is likely to update a 2020 guidance to better address the problem according…
Some batches of Januvia, a diabetes drug, contain high levels of nitrosamines which could increase cancer risks, the FDA warns.
Pfizer is recalling five lots of Accupril, a hypertension drug, due to the risk of nitrosamine contamination and long-term cancer risk.
Pfizer is recalling several lots of Accuretic hypertension drugs due to the presence of potentially cancer-causing chemicals.
Canadian health regulators have announced an Accuretic recall, indicating the Pfizer hypertension drug contains levels of cancer-causing chemicals above the acceptable amounts.
A class action lawsuit claims the presence of potentially cancer-causing chemicals made Chantix an illegal and unadulterated drug which was never approved by the FDA.
A class action lawsuit filed after a recent Chantix recall claims the drug was illegally marketed due to the lack of warnings that it may contain cancer-causing substances.
A recent Chantix recall has resulted in a class action lawsuit against Pfizer, which claims the company sold a defective drug to consumers which put them at an increased risk…